Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Or-Genix Therapeutics

Or-Genix Therapeutics?uq=w9if130k
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$200K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of non-prescription and prescription dermatology products. The company develops patented prescription and non-prescription (cosmeceutical) topical products for hormonally aging skin.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
  • 8 Canterbury Lane
  • Holden, MA 01520
  • United States

+1 (774) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Or-Genix Therapeutics’s full profile, request a free trial.

Or-Genix Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 16-Dec-2015 $200K 00000 Completed Startup
1. Accelerator/Incubator 01-May-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Or-Genix Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Gore Range Capital Venture Capital Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0

Or-Genix Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Yael Schwartz Ph.D Founder, Chief Executive Officer & President